Evidence map›Paper›PMID 26373701›Full record

Trial reportObesity (Silver Spring, Md.)2015

Relationship of insulin dynamics to body composition and resting energy expenditure following weight loss.

Bridget M Hron, Cara B Ebbeling, Henry A Feldman, David S Ludwig

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Obesity (Silver Spring, Md.), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Bridget M HronDivision of Gastroenterology, Hepatology and Nutrition, Boston Children's Hospital, Boston, Massachusetts, USA.
Cara B EbbelingNew Balance Foundation Obesity Prevention Center, Boston Children's Hospital, Boston, Massachusetts, USA.
Henry A FeldmanClinical Research Center, Boston Children's Hospital, Boston, Massachusetts, USA.
David S LudwigNew Balance Foundation Obesity Prevention Center, Boston Children's Hospital, Boston, Massachusetts, USA.

Funding

HARVARD CLINICAL AND TRANSLATIONAL SCIENCE CENTER (UL1)UL1RR025758 · NCRR · HARVARD MEDICAL SCHOOL · PI NADLER, LEE MARSHALL · 2008 to 2011
$91.4M
Zoledronic Acid in Treatment of Osteoporosis in PostmenoM01RR002635 · NCRR · BRIGHAM AND WOMEN'S HOSPITAL · PI WILLIAMS, GORDON H · 1985 to 2008
$48.4M
STRUCTURE-FUNCTION RELATIONSHIPS IN THE ALIMENTARY TRACTP30DK034854 · NIDDK · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI JONATHAN C KAGAN · 1986 to 2026
$32.4M
ROLE OF DIETARY CONSTITUENTS ON GENE EXPRESSION IN INTESTINAL EPITHELIUMP30DK040561 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI Elizabeth Austen Lawson, Takara Leah Stanley · 1994 to 2026
$31.6M
WIRELESS CAPSULE ENDOSCOPY TO EVALUATE THE SMALL INTESTINE M01RR002172 · NCRR · CHILDREN'S HOSPITAL BOSTON · PI MANDELL, JAMES WILLIAM · 1985 to 2008
$16.0M
TRAINING IN PEDIATRIC GASTROENTEROLOGY &NUTRITIONT32DK007477 · NIDDK · CHILDREN'S HOSPITAL BOSTON · PI Scott B Snapper · 1986 to 2026
$13.3M
Popular Diets, Metabolism, and CVD RiskR01DK072428 · NIDDK · CHILDREN'S HOSPITAL BOSTON · PI LUDWIG, DAVID S · 2005 to 2008
$1.9M
Effects of Diet on Hormones, Metabolism and Body WeightK24DK082730 · NIDDK · BOSTON CHILDREN'S HOSPITAL · PI LUDWIG, DAVID S · 2009 to 2018
$1.6M
Effects of Anti-Inflammatory Diet on Pulmonary Function in Pediatric AsthmaF32HL122080 · NHLBI · BOSTON CHILDREN'S HOSPITAL · PI HRON, BRIDGET MARY · 2014 to 2015
$128k
NCRR NIH HHS M01 RR002172NCRR NIH HHS M01 RR002635NCRR NIH HHS M01RR02172NCRR NIH HHS M01RR02635NCRR NIH HHS UL1 RR025758NCRR NIH HHS UL1RR02575801NHLBI NIH HHS F32 HL122080NHLBI NIH HHS F32HL122080-01NIDDK NIH HHS K24 DK082730NIDDK NIH HHS K24DK082730NIDDK NIH HHS P30 DK034854NIDDK NIH HHS P30 DK040561NIDDK NIH HHS R01 DK072428NIDDK NIH HHS R01DK072428NIDDK NIH HHS T32 DK007477NIDDK NIH HHS T32 DK007477-31
6 · The paper itself

Abstract

objectiveTo examine associations of baseline insulin dynamics with changes in body composition and resting energy expenditure (REE) following weight loss.

methodsTwenty-one participants with overweight or obesity achieved 10-15% weight loss and then received 3 weight loss maintenance diets (high-carbohydrate, moderate-carbohydrate, and low-carbohydrate) in random order, each for 4 weeks. Body composition was measured at baseline and after weight loss. Insulin 30 min after glucose consumption (insulin-30; insulin response), C-peptide deconvolution analysis, HOMA, hepatic insulin sensitivity (IS), and REE were assessed at baseline and after each maintenance diet.

resultsInsulin-30, but not maximal insulin secretion, hepatic IS, or HOMA, predicted changes in fat mass (standardized β = 0.385, 1.7 kg difference between 10th and 90th centile of insulin-30, P = 0.04) after weight loss. Insulin-30 (β = -0.341, -312 kcal day(-1) , P = 0.008), maximal insulin secretion (β = -0.216, -95 kcal day(-1) , P = 0.0002), HOMA (β = -0.394, -350 kcal day(-1) , P = 0.002), and hepatic IS (β = 0.217, 225 kcal day(-1) , P = 0.0003) predicted change in REE during weight loss maintenance, independent of changes in body composition. The inverse relationship between insulin-30 and REE was substantially attenuated when the low-carbohydrate diet was consumed first.

conclusionsThese findings distinguish a novel phenotype, characterized by high insulin response, at risk for weight regain, and identify a dietary approach to ameliorate this risk.

Indexed as

RestAdultBody CompositionBody WeightC-PeptideDiet, Carbohydrate-RestrictedDiet, ReducingEnergy MetabolismFemaleHumansInsulinInsulin ResistanceMaleObesityOverweightWeight LossC-PeptideInsulin

Identifiers

PMID26373701
PMCPMC4633340

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.